Join to view full profile
500 University DrHershey, PA 17033
Phone+1 800-233-4082
Fax+1 717-531-4694
Dr. Thomas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Clinical Neurophysiology, 2005 - 2006- Penn State Milton S Hershey Medical CenterResidency, Neurology, 2002 - 2005
- Penn State Milton S Hershey Medical CenterInternship, Transitional Year, 2001 - 2002
Pennsylvania State University College of MedicineClass of 2001
Certifications & Licensure
PA State Medical License 2001 - 2026
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2013, 2015, 2017
Publications & Presentations
PubMed
- 6 citationsLow-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic.Patricia J McLaughlin, Laura B Odom, Peter A Arnett, Shannon Orehek, Gary A Thomas
International Immunopharmacology. 2022-12-01 - 3 citationsβ-endorphin and opioid growth factor as biomarkers of physical ability in multiple sclerosis.Chirag Patel, Gary A. Thomas, Naseem Zomorodi, Ian S. Zagon, Patricia J. McLaughlin
Multiple Sclerosis and Related Disorders. 2021-02-27 - 4 citationsWhat does the research say about androgen use and cerebrovascular eventsM. Reza Sadaie, Mehdi Farhoudi, Masumeh Zamanlu, Nasser Aghamohammadzadeh, Atieh Amouzegar
Therapeutic Advances in Drug Safety. 2018-05-08
Grant Support
- Impact of the E209K PACS2 Syndrome mutation on neuronal metabolism and neurotransmission.UNIVERSITY OF PITTSBURGH AT PITTSBURGH2024–2029
- Molecular, Cellular and Behavioral Impact of the R203W PACS1 Syndrome MutationUNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: